{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:24:45Z","timestamp":1772785485430,"version":"3.50.1"},"reference-count":31,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2002,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The therapeutic efficacy of KP-103, a novel topical triazole, in a guinea pig tinea unguium model was investigated. Experimental tinea unguium and tinea pedis were produced by inoculation of<jats:italic>Trichophyton mentagrophytes<\/jats:italic>SM-110 between the toes of the hind paw of guinea pigs. One percent solution (0.1 ml) of KP-103, amorolfine, or terbinafine was topically applied to the nails and whole sole of an infected foot once daily for 30 consecutive days, and terbinafine was also orally administered at a daily dose of 40 mg\/kg of body weight for 30 consecutive days, starting on day 60 postinfection. The fungal burdens of nails and plantar skin were assessed using a new method, which makes it possible to recover infecting fungi by removing a carryover of the drug remaining in the treated tissues into the culture medium. Topically applied KP-103 inhibited the development of nail collapse, significantly reduced the fungal burden of the nails, and sterilized the infected plantar skin. On the other hand, topical amorolfine and topical or oral terbinafine were ineffective for tinea unguium, although these drugs eradicated or reduced the fungal burden of plantar skin. The in vitro activities of amorolfine and terbinafine against<jats:italic>T. mentagrophytes<\/jats:italic>SM-110 were 8- and 32-fold, respectively, decreased by the addition of 5% keratin to Sabouraud dextrose broth medium. In contrast, the activity of KP-103 was not affected by keratin because its keratin affinity is lower than those of the reference drugs, suggesting that KP-103 largely exists in the nails as an active form that was not bound to keratin and diffuses in the nail without being trapped by keratin. The effectiveness of KP-103 against tinea unguium is probably due to its favorable pharmacokinetic properties in the nails together with its potent antifungal activity.<\/jats:p>","DOI":"10.1128\/aac.46.12.3797-3801.2002","type":"journal-article","created":{"date-parts":[[2002,11,15]],"date-time":"2002-11-15T15:02:26Z","timestamp":1037372546000},"page":"3797-3801","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":62,"title":["Therapeutic Efficacy of Topically Applied KP-103 against Experimental Tinea Unguium in Guinea Pigs in Comparison with Amorolfine and Terbinafine"],"prefix":"10.1128","volume":"46","author":[{"given":"Yoshiyuki","family":"Tatsumi","sequence":"first","affiliation":[{"name":"Central Research Laboratories, Kaken Pharmaceutical Co., Ltd., Shinomiya, Yamashina-ku, Kyoto-city, Kyoto 607-8042"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Yokoo","sequence":"additional","affiliation":[{"name":"Central Research Laboratories, Kaken Pharmaceutical Co., Ltd., Shinomiya, Yamashina-ku, Kyoto-city, Kyoto 607-8042"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisato","family":"Senda","sequence":"additional","affiliation":[{"name":"Central Research Laboratories, Kaken Pharmaceutical Co., Ltd., Shinomiya, Yamashina-ku, Kyoto-city, Kyoto 607-8042"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Kakehi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences of Kinki University, Kowakae, Higashi-Osaka-shi, Osaka 557-0818, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.2.363"},{"key":"e_1_3_1_3_2","first-page":"481","volume":"123","year":"1990","unstructured":"Dykes, P. J., R. Thomas, and A. Y. Finlay. 1990. Determination of terbinafine in nail sample during systemic treatment for onychomycosis. B. J. Dermatol.123:481-486.","journal-title":"B. J. Dermatol."},{"key":"e_1_3_1_4_2","first-page":"74","volume":"77","year":"1996","unstructured":"Faergemann, J., H. Zehender, A. Boukhabza, S. G. Smith, and T. C. Jones. 1996. A double-blind comparison of levels of terbinafine and itraconazole in plasma, skin, sebum, hair, and nails during and after oral medication. Acta Dermatol. Venereol.77:74-77.","journal-title":"Acta Dermatol. Venereol."},{"key":"e_1_3_1_5_2","first-page":"1151","volume":"302","year":"1992","unstructured":"Goodfield, M., L. Andrew, and E. G. Evans. 1992. Short term treatment of dermatophyte onychomycosis with terbinafine. Br. Med. J.302:1151-1154.","journal-title":"Br. Med. J."},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0190-9622(99)70055-1","volume":"41","year":"1999","unstructured":"Gupta, A. K., H. I. Katz, and N. H. Shear. 1999. Drug interactions with itraconazole, fluconazole, and terbinafine and their management. J. Am. Acad. Dermatol.41:237-249.","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200022010-00004"},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2000.109071","volume":"43","year":"2000","unstructured":"Gupta, A. K., P. Fleckman, and R. Baran. 2000. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. J. Am. Acad. Dermatol.43:S70-S80.","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2165\/00003495-199549010-00008","volume":"49","year":"1995","unstructured":"Haria, M., and H. M. Bryson. 1995. Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections. Drugs49:103-120.","journal-title":"Drugs"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-4362.2001.01039.x","volume":"40","year":"2001","unstructured":"Jain, S., and V. N. Sehgal. 2001. Itraconazole: an effective oral antifungal for onychomycosis. Int. J. Dermatol.40:1-5.","journal-title":"Int. J. Dermatol."},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/archderm.1992.01680120115015","volume":"128","year":"1992","unstructured":"Korting, H. C., and M. S. Korting. 1992. Is tinea unguium still widely in curable? A review three decade after the introduction of griseofulvin. Arch. Dermatol.128:243-248.","journal-title":"Arch. Dermatol."},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1248\/yakushi1947.111.2_126","volume":"111","year":"1991","unstructured":"Maeda, T., M. Takase, A. Ishibashi, T. Yamamoto, K. Sasaki, T. Arika, M. Yokoo, and K. Amemiya. 1991. Synthesis and antifungal activity of butenafine hydrochroride (KP-363), a new benzylamine antifungal agent. Yakugaku Zasshi111:126-137.","journal-title":"Yakugaku Zasshi"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199958010-00018"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00003495-199958020-00005","volume":"58","year":"1999","unstructured":"Niewerth, M. 1999. Management of onychomycosis. Drugs58:283-296.","journal-title":"Drugs"},{"key":"e_1_3_1_15_2","first-page":"1056","volume":"47","year":"1997","unstructured":"Niwano, Y., M. Matsui, T. Tabuchi, K. Kanai, H. Hamaguchi, T. Miyazaki, and K. Uchida, and H. Yamaguchi. 1997. Studies on the antifungal activity of the new imidazole antimycotic lanoconazole in infected sites. Arzneim-Forsch.\/Drug Res.47:1056-1060.","journal-title":"Arzneim-Forsch.\/Drug Res."},{"key":"e_1_3_1_16_2","first-page":"146","volume":"48","year":"1995","unstructured":"Niwano, Y., K. Kanai, H. Hamaguchi, K. Uchida, and H. Yamaguchi. 1995. Studies on the in vitro antifungal activity of lanoconazole, a new topical antimycotic, against Trichophyton spp. Jpn. J. Antibiot.48:146-149.","journal-title":"Jpn. J. Antibiot."},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1248\/cpb.47.1417","volume":"47","year":"1999","unstructured":"Ogura, H., H. Kobayashi, K. Nagai, T. Nishida, T. Naito, Y. Tatsumi, M. Yokoo, and T. Arika. 1999. Synthesis and antifungal activities of (2R, 3R)-2-aryl-1-azolyl-3-(substituted amino)-2-butanol derivatives as a topical antifungal agent. Chem. Pharm. Bull.47:1417-1425.","journal-title":"Chem. Pharm. Bull."},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.19.3.390"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.9.1365"},{"key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1439-0507.1993.tb00696.x","volume":"36","year":"1993","unstructured":"Polak, A. 1993. Kinetics of amorolfine in human nails. Mycoses36:101-103.","journal-title":"Mycoses"},{"key":"e_1_3_1_21_2","first-page":"1","volume":"141","year":"1999","unstructured":"Roberts, D. T. 1999. Onychomycosis: current treatment and future challenges. Br. J. Dermatol.141:1-4.","journal-title":"Br. J. Dermatol."},{"key":"e_1_3_1_22_2","first-page":"353","volume":"138","year":"2002","unstructured":"Sigurgeirsson, B., J. H. Olafsson, J. B. Steinsson, C Paul, S. Billstein, and E. G. Evans. 2002. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study. Arch. Dermatol.138:353-357.","journal-title":"Arch. Dermatol."},{"key":"e_1_3_1_23_2","unstructured":"Takahashi H. A. Hasegawa O. Kaneko A. Saito and Y. Tanaka. 1986. Clinical studies of fungicidal agents with respect to their relationship in vitro and in vivo p. 227-240. In K. Iwata and H. Vanden Bossche (ed.) In vitro and in vivo evaluation of antifungal agents. Elsevier Science Publishers Amsterdam The Netherlands."},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1346-8138.1999.tb03517.x","volume":"26","year":"1999","unstructured":"Tanuma, H. 1999. Current topics in diagnosis and treatment of tinea unguium in Japan. J. Dermatol.26:87-97.","journal-title":"J. Dermatol."},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.5.1493-1499.2001"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2002.tb02716.x"},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1348-0421.2002.tb02717.x","volume":"46","year":"2002","unstructured":"Tatsumi, Y., M. Yokoo, T. Arika, and H. Yamaguchi. 2002. In vivo fungicidal effect of KP-103 in a guinea pig model of interdigital tinea pedis determined by using a new method for removing the antimycotic carryover effect. Microbiol. Immunol.46:433-439.","journal-title":"Microbiol. Immunol."},{"key":"e_1_3_1_28_2","first-page":"414","volume":"54","year":"1988","unstructured":"Tauber, U. 1988. Pharmacokinetics of antimycotics with emphasis on local treatment. Ann. N. Y. Acad. Sci.54:414-426.","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"e_1_3_1_29_2","first-page":"1007","volume":"44","year":"1991","unstructured":"Uchida, K., K. Aoki, and H. Yamaguchi. 1991. In vitro antifungal activities of amorolfine against fresh isolates from patients with cutaneous mycosis. Jpn. J. Antibiot.44:1007-1012.","journal-title":"Jpn. J. Antibiot."},{"key":"e_1_3_1_30_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3314\/jjmm.34.207","volume":"34","year":"1993","unstructured":"Uchida, K., and H. Yamaguchi. 1993. Studies on the affinity of terbinafine with keratin. Jpn. J. Med. Mycol.34:207-212.","journal-title":"Jpn. J. Med. Mycol."},{"key":"e_1_3_1_31_2","first-page":"36","volume":"39","year":"1992","unstructured":"Van der schroff, J. G., P. K. S. Cirkel, M. B. Crijns, T. J. A. Van Dijk, F. J. Govaert, D. A. Groeneweg, D. J. Tazelaar, R. F. E. De Wit, and J. Wuite. 1992. A randomized treatment duration-finding study of terbinafine in onychomycosis. Br. J. Dermatol.39:36-39.","journal-title":"Br. J. Dermatol."},{"key":"e_1_3_1_32_2","first-page":"61","volume":"39","year":"1992","unstructured":"Villars, V. V., and T. C. Jones. 1992. Special features of the clinical use of oral terbinafine in the treatment of fungal diseases. Br. J. Dermatol.39:61-69.","journal-title":"Br. J. Dermatol."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.46.12.3797-3801.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.46.12.3797-3801.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T18:31:09Z","timestamp":1704652269000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.46.12.3797-3801.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["10.1128\/AAC.46.12.3797-3801.2002"],"URL":"https:\/\/doi.org\/10.1128\/aac.46.12.3797-3801.2002","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12]]},"assertion":[{"value":"2002-05-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-08-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}